IGC Pharma, Inc.IGCNYSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank71
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P71
Within normal range
vs 2Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202524.00%
202415.32%
202325.00%
2022-76.85%
2021-27.10%
2020-47.84%
2019-159.53%
201812.90%
201729.32%
201633.07%